Hospital Universitario de Valme
12
2
2
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Development of a Predictive Model for Sexually Transmitted Infections in Individuals Using Pre-Exposure Prophylaxis for HIV in Spain
Role: lead
PREMAPROB. Probiotics to Prevent Necrotizing Enterocolitis
Role: collaborator
Natural History of Clostridioides Difficile Infection
Role: lead
Program of Supervised Occlusive Aerobic Training in People With Fibromyalgia.
Role: collaborator
RWD Patients With Pulmonary Arterial Hypertension Treated With IP Prostacyclin Receptor Agonists
Role: collaborator
Hepatocellular Carcinoma in HIV-infected Patients
Role: lead
Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients
Role: lead
Repair by Rehabilitation of Pelvic Floor Lesions After Vaginal Delivery Identified by Transperineal Ultrasound 3/4 D
Role: lead
Prediction of Liver-related Outcomes After HCV Cure
Role: lead
Forceps vs Vacuum. Rate of Levator Ani Muscle Avulsion: Clinical Trial.
Role: lead
Role of Rehabilitation for the Repair of Pelvic Floor Injuries Associated to Vaginal Delivery Identified by 3/4D Transperineal Ultrasound
Role: lead
Individualized Perioperative Open Lung Ventilatory Strategy
Role: collaborator
All 12 trials loaded